Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 15
1966 9
1967 13
1968 11
1969 29
1970 22
1971 22
1972 44
1973 50
1974 56
1975 57
1976 39
1977 53
1978 37
1979 62
1980 55
1981 69
1982 98
1983 93
1984 76
1985 109
1986 118
1987 133
1988 109
1989 138
1990 121
1991 112
1992 118
1993 130
1994 110
1995 141
1996 138
1997 135
1998 178
1999 148
2000 126
2001 131
2002 122
2003 118
2004 123
2005 119
2006 119
2007 131
2008 103
2009 80
2010 76
2011 111
2012 107
2013 101
2014 106
2015 113
2016 90
2017 75
2018 57
2019 69
2020 57
2021 65
2022 83
2023 74
2024 30

Text availability

Article attribute

Article type

Publication date

Search Results

5,049 results

Results by year

Filters applied: . Clear all
Page 1
Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes. A randomized controlled trial. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.
Mercer BM, Miodovnik M, Thurnau GR, Goldenberg RL, Das AF, Ramsey RD, Rabello YA, Meis PJ, Moawad AH, Iams JD, Van Dorsten JP, Paul RH, Bottoms SF, Merenstein G, Thom EA, Roberts JM, McNellis D. Mercer BM, et al. JAMA. 1997 Sep 24;278(12):989-95. JAMA. 1997. PMID: 9307346 Clinical Trial.
PATIENTS: A total of 614 of 804 eligible gravidas with PPROM between 24 weeks' and 0 days' and 32 weeks' and 0 days' gestation who were considered candidates for pregnancy prolongation and had not received corticosteroids for fetal maturation or antibiotic treatment within 1 week …
PATIENTS: A total of 614 of 804 eligible gravidas with PPROM between 24 weeks' and 0 days' and 32 weeks' and 0 days' gestation who were cons …
Simultaneous pharmacokinetic/pharmacodynamic (PKPD) assessment of ampicillin and gentamicin in the treatment of neonatal sepsis.
Gastine S, Obiero C, Kane Z, Williams P, Readman J, Murunga S, Thitiri J, Ellis S, Correia E, Nyaoke B, Kipper K, van den Anker J, Sharland M, Berkley JA, Standing JF. Gastine S, et al. J Antimicrob Chemother. 2022 Feb 2;77(2):448-456. doi: 10.1093/jac/dkab413. J Antimicrob Chemother. 2022. PMID: 35107141 Free PMC article. Clinical Trial.
METHODS: Pharmacokinetic data were collected in 59 neonates receiving ampicillin and gentamicin for suspected or proven sepsis in the NeoFosfo trial (NCT03453177). ...RESULTS: A model was established that simultaneously estimated parameters of a one-compartment ampicill
METHODS: Pharmacokinetic data were collected in 59 neonates receiving ampicillin and gentamicin for suspected or proven sepsis in the …
Prostatic Pharmacokinetic/Pharmacodynamic Evaluation of Ampicillin-Sulbactam for Bacterial Prostatitis and Preoperative Prophylaxis.
Onita T, Ikawa K, Nakamura K, Nishikawa G, Kobayashi I, Ishihara N, Tamaki H, Yano T, Naora K, Morikawa N. Onita T, et al. J Clin Pharmacol. 2021 Jun;61(6):820-831. doi: 10.1002/jcph.1800. Epub 2021 Jan 12. J Clin Pharmacol. 2021. PMID: 33314138 Clinical Trial.
This study aims to define the penetration of ampicillin and sulbactam into prostate tissue, develop a prostatic pharmacokinetic model of each drug, and assess the appropriateness of ampicillin-sulbactam regimens for the treatment of prostatitis and the prophylaxis o …
This study aims to define the penetration of ampicillin and sulbactam into prostate tissue, develop a prostatic pharmacokinetic model …
Therapy of antimicrobial-resistant typhoid fever.
Butler T, Linh NN, Arnold K, Adickman MD, Chau DM, Muoi MM. Butler T, et al. Antimicrob Agents Chemother. 1977 Apr;11(4):645-50. doi: 10.1128/AAC.11.4.645. Antimicrob Agents Chemother. 1977. PMID: 324398 Free PMC article. Clinical Trial.
The clinical trial of ampicillin and TMP-SMZ showed that both drugs were equally effective. ...Therefore, in an area where antimicrobial-resistant typhoid fever exists, patients with R isolates should receive either ampicillin or TMP-SMZ, but patients with S isolate …
The clinical trial of ampicillin and TMP-SMZ showed that both drugs were equally effective. ...Therefore, in an area where antimicrob …
Bioequivalence study of sultamicillin suspensions.
Sailer R, Arnold P, Erenmemişoğlu A, Martin W, Tamur U, Kanzik I, Hincal AA. Sailer R, et al. Arzneimittelforschung. 2007;57(4):232-7. doi: 10.1055/s-0031-1296610. Arzneimittelforschung. 2007. PMID: 17515294 Clinical Trial.
The median t(max) was 0.69 h (ampicillin, test), 0.85 h (ampicillin, reference), 0.72 h (sulbactam, Devasid) and 0.83 h (sulbactam, reference). Plasma elimination half-lives (t(1/2)) of 1.04 h (ampicillin, test), 1.03 h (ampicillin, reference), 1.26 h …
The median t(max) was 0.69 h (ampicillin, test), 0.85 h (ampicillin, reference), 0.72 h (sulbactam, Devasid) and 0.83 h (sulba …
Ampicillin and sulbactam pharmacokinetics and pharmacodynamics in continuous ambulatory peritoneal dialysis (CAPD).
Blackwell BG, Leggett JE, Johnson CA, Zimmerman SW, Craig WA. Blackwell BG, et al. Perit Dial Int. 1990;10(3):221-6. Perit Dial Int. 1990. PMID: 2099158 Clinical Trial.
The fixed combination antibiotic ampicillin/sulbactam may provide a new, safe, and effective method of treating dialysis-related bacterial peritonitis. ...Ampicillin/sulbactam (2 gm/1 gm) should be administered every 12 h to patients with peritoneal dialysis-related …
The fixed combination antibiotic ampicillin/sulbactam may provide a new, safe, and effective method of treating dialysis-related bact …
Ampicillin dosage and use of prednisolone in treatment of pneumonia: co-operative controlled trial.
McHardy VU, Schonell ME. McHardy VU, et al. Br Med J. 1972 Dec 9;4(5840):569-73. doi: 10.1136/bmj.4.5840.569. Br Med J. 1972. PMID: 4404939 Free PMC article. Clinical Trial.
A controlled trial was carried out to investigate whether the rate of recovery from pneumonia treated with ampicillin is dose related. Sixty-three patients received 1 g ampicillin daily and 63 received 2 g ampicillin daily for seven or 14 days depending on th …
A controlled trial was carried out to investigate whether the rate of recovery from pneumonia treated with ampicillin is dose related …
Clinical evaluation of sulbactam/ampicillin in Japan.
Shimada K. Shimada K. Diagn Microbiol Infect Dis. 1989 Jul-Aug;12(4 Suppl):171S-174S. doi: 10.1016/0732-8893(89)90131-4. Diagn Microbiol Infect Dis. 1989. PMID: 2686916 Clinical Trial.
A total of 754 patients were treated intravenously with sulbactam/ampicillin, in a clinical trial to determine the efficacy and safety of the drug. ...In the treatment of respiratory and urinary tract infections, efficacy was 82.5% and 77.1%, respectively. Overall, sulbact …
A total of 754 patients were treated intravenously with sulbactam/ampicillin, in a clinical trial to determine the efficacy and safet …
[Comparative clinical trial of cefoperazone versus ampicillin + tobramycin in severe bronchopulmonary and pleural infectious pathology].
Vergnon JM, Vincent M, Ros A, Brun Y, Brune J. Vergnon JM, et al. Rev Pneumol Clin. 1985;41(3):205-11. Rev Pneumol Clin. 1985. PMID: 4048752 Clinical Trial. French.
No significant difference was seen in the sampling of the two populations. Cefoperazone was prescribed in 2 infusions per 24 hours. Ampicillin was given as 3 infusions, followed by tobramycin administered by a similar number of injections. The duration of treatment was 16. …
No significant difference was seen in the sampling of the two populations. Cefoperazone was prescribed in 2 infusions per 24 hours. Ampic
5,049 results